Hoyle C H, Postorino A, Burnstock G
Department of Anatomy and Developmental Biology, University College London, UK.
J Pharm Pharmacol. 1995 Nov;47(11):926-31. doi: 10.1111/j.2042-7158.1995.tb03272.x.
The pre- and postjunctional activities of a number of diadenosine polyphosphates were examined in the guinea-pig isolated vas deferens at the level of the membrane potential, using a modified sucrose-gap technique. P1,P3-Di(adenosine 5')triphosphate (Ap3A), P1,P4-di(adenosine 5')tetraphosphate (Ap4A) and P1,P5-di(adenosine 5')pentaphosphate (Ap5A) all caused concentration-dependent depolarization of the smooth muscle membrane. The potency order was: Ap5A > Ap4A > or = Ap3A. P1,P2-Di(adenosine 5')pyrophosphate (Ap2A) did not evoke depolarization even at the highest concentration tested (1 mM). All the dinucleotides caused a reduction in the amplitude of evoked excitatory junction potentials (e.j.ps). The potency order was: Ap5A = Ap4A > Ap3A > Ap2A. The depolarizations evoked by the dinucleotides were markedly reduced by the selective P2X-purinoceptor antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, 10 microM), as was the amplitude of the fully facilitated e.j.p. The inhibition of the e.j.p. evoked by Ap3A and Ap2A was reduced by the P1-purinoceptor antagonist, 8-p-sulphophenyltheophylline (8-pSPT, 50 microM), but that evoked by Ap5A and Ap4A was not. Thus, Ap3A, Ap4A and Ap5A evoke depolarization of the guinea-pig vas deferens via P2X-purinoceptors, and additionally Ap2A and Ap3A exert a prejunctional effect via P1-purinoceptors. The prejunctional activity of Ap4A and Ap5A is mediated via an undefined purinoceptor, which is neither P1 nor P2X.
采用改良的蔗糖间隙技术,在豚鼠离体输精管上,于膜电位水平检测了多种二腺苷多磷酸的接头前和接头后活性。P1,P3-二(腺苷5′)三磷酸(Ap3A)、P1,P4-二(腺苷5′)四磷酸(Ap4A)和P1,P5-二(腺苷5′)五磷酸(Ap5A)均引起平滑肌膜浓度依赖性去极化。效价顺序为:Ap5A>Ap4A≥Ap3A。P1,P2-二(腺苷5′)焦磷酸(Ap2A)即使在最高测试浓度(1 mM)时也未引起去极化。所有二核苷酸均导致诱发的兴奋性接头电位(e.j.ps)幅度降低。效价顺序为:Ap5A = Ap4A>Ap3A>Ap2A。二核苷酸诱发的去极化被选择性P2X嘌呤受体拮抗剂吡哆醛磷酸-6-偶氮苯-2′,4′-二磺酸(PPADS,10 μM)显著降低,完全易化的e.j.p.幅度也如此。Ap3A和Ap2A诱发的e.j.p.抑制被P1嘌呤受体拮抗剂8-对磺基苯茶碱(8-pSPT,50 μM)降低,但Ap